Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01336634
Brief Title: Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.

First Submitted : April 7, 2011
First Submitted that Met QC Criteria : April 14, 2011
First Posted : April 18, 2011 (Estimate)

Results First Submitted : October 5, 2016
Results First Submitted that Met QC Criteria : November 3, 2017
Results First Posted : December 7, 2017

Last Update Submitted that Met QC Criteria : May 7, 2018
Last Update Posted : May 9, 2018